Xiangwei Xu

Hangzhou, 310013, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Correction: Discovery of novel METTL3 inhibitors: design, synthesis, and in silico and in vitro evaluations.

Correction: Discovery of novel METTL3 inhibitors: design, synthesis, and in silico and in vitro evaluations.

Journal: RSC advances

Published: July 23, 2026

Discovery of novel METTL3 inhibitors: design, synthesis, and in silico and in vitro evaluations.

Discovery of novel METTL3 inhibitors: design, synthesis, and in silico and in vitro evaluations.

Journal: RSC advances

Published: April 05, 2026

Arteannuin B, a novel NLRP3 inhibitor, suppresses NLRP3 inflammasome in macrophages and alleviates NLRP3-related diseases.

Arteannuin B, a novel NLRP3 inhibitor, suppresses NLRP3 inflammasome in macrophages and alleviates NLRP3-related diseases.

Journal: International immunopharmacology

Published: October 25, 2025

Folate-ClipTAC: Design and Proof of Concept Study.

Folate-ClipTAC: Design and Proof of Concept Study.

Journal: Current medicinal chemistry

Published: October 05, 2025

Recent progress of METTL3 inhibitors for cancer therapeutics: design, optimization and potential applications.

Recent progress of METTL3 inhibitors for cancer therapeutics: design, optimization and potential applications.

Journal: RSC medicinal chemistry

Published: September 26, 2025

Selective cytotoxicity of anhydroicaritin in ER-positive breast cancer via ESR1-mediated MAPK and apoptotic signaling.

Selective cytotoxicity of anhydroicaritin in ER-positive breast cancer via ESR1-mediated MAPK and apoptotic signaling.

Journal: Chemico-biological interactions

Published: August 12, 2025

PDL1-inhi.predictor: a two-tiered machine learning framework for predicting and prioritizing PDL1 inhibitors.

PDL1-inhi.predictor: a two-tiered machine learning framework for predicting and prioritizing PDL1 inhibitors.

Journal: Bioorganic chemistry

Published: July 03, 2025

Discovery of Novel HPK1 Inhibitors via High-Throughput Virtual Screening, Biological Evaluation, and Molecular Dynamics Simulation.

Discovery of Novel HPK1 Inhibitors via High-Throughput Virtual Screening, Biological Evaluation, and Molecular Dynamics Simulation.

Journal: Archiv der Pharmazie

Published: July 03, 2025

Isolinderalactone regulates macrophage polarization and efferocytosis by activating the LXRα pathway against ulcerative colitis.

Isolinderalactone regulates macrophage polarization and efferocytosis by activating the LXRα pathway against ulcerative colitis.

Journal: Chinese medicine

Published: May 14, 2025

Taxifolin Attenuates Cisplatin-Induced Acute Kidney Injury by Promoting Fatty Acid Oxidation.

Taxifolin Attenuates Cisplatin-Induced Acute Kidney Injury by Promoting Fatty Acid Oxidation.

Journal: Journal of biochemical and molecular toxicology

Published: April 07, 2025

Discovery and characterization of novel FAK inhibitors for breast cancer therapy via hybrid virtual screening, biological evaluation and molecular dynamics simulations.

Discovery and characterization of novel FAK inhibitors for breast cancer therapy via hybrid virtual screening, biological evaluation and molecular dynamics simulations.

Journal: Bioorganic chemistry

Published: January 10, 2025

Integrated Network Pharmacology, Machine Learning and Experimental Validation to Identify the Key Targets and Compounds of TiaoShenGongJian for the Treatment of Breast Cancer.

Integrated Network Pharmacology, Machine Learning and Experimental Validation to Identify the Key Targets and Compounds of TiaoShenGongJian for the Treatment of Breast Cancer.

Journal: OncoTargets and therapy

Published: August 29, 2024

Showing 1-12 of 37

Last Updated: 09/26/2026